
NeoGenomics, Inc. (NASDAQ:NEO) Given Average Recommendation of “Hold” by Analysts
NeoGenomics, Inc. (NASDAQ: NEO - Get Free Report) has received a consensus recommendation of "Hold" from the thirteen brokerages that are currently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, six have given a hold recommendation, five have given a buy recommendation and one has given


















